147 related articles for article (PubMed ID: 3894752)
1. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency.
Katzav S; Segal S; Feldman M
J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752
[TBL] [Abstract][Full Text] [Related]
2. Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells.
Katzav S; De Baetselier P; Tartakovsky B; Feldman M; Segal S
J Natl Cancer Inst; 1983 Aug; 71(2):317-24. PubMed ID: 6576189
[TBL] [Abstract][Full Text] [Related]
3. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
4. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
5. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
Mandelboim O; Feldman M; Eisenbach L
J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
[TBL] [Abstract][Full Text] [Related]
6. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma.
Carlow DA; Kerbel RS; Feltis JT; Elliott BE
J Natl Cancer Inst; 1985 Aug; 75(2):291-301. PubMed ID: 2410653
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties.
Isakov N; Katzav S; Feldman M; Segal S
J Natl Cancer Inst; 1983 Jul; 71(1):139-45. PubMed ID: 6345878
[TBL] [Abstract][Full Text] [Related]
9. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
Gorelik E; Peppoloni S; Overton R; Herberman RB
Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992
[TBL] [Abstract][Full Text] [Related]
10. Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.
Milisauskas VK; Kaminsky SG; Nakamura I
Eur J Immunol; 1987 Jul; 17(7):1043-9. PubMed ID: 2440692
[TBL] [Abstract][Full Text] [Related]
11. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.
Geldhof AB; Raes G; Bakkus M; Devos S; Thielemans K; De Baetselier P
Cancer Res; 1995 Jul; 55(13):2730-3. PubMed ID: 7540948
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T cell lysis of H-2-negative murine sarcoma cells.
Noll G; Schmidt W; Bauer H
Eur J Immunol; 1986 May; 16(5):531-6. PubMed ID: 3486129
[TBL] [Abstract][Full Text] [Related]
13. Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines.
Tomonari K
J Immunol; 1983 Oct; 131(4):1641-5. PubMed ID: 6194209
[TBL] [Abstract][Full Text] [Related]
14. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
15. Immuno-selection in vivo of H-2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence.
Katzav S; Segal S; Feldman M
Int J Cancer; 1984 Mar; 33(3):407-15. PubMed ID: 6698640
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the H-2Dk MHC class-I antigen and tissue inhibitor of metalloproteinases in metastatic and nonmetastatic T-10 fibrosarcoma cells.
Har-Vardi I; Gopas J; Rager-Zisman B; Hammerling GJ; Segal S; Aboud M
Invasion Metastasis; 1992; 12(5-6):301-8. PubMed ID: 1298741
[TBL] [Abstract][Full Text] [Related]
17. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Kim M; Duty L; Herberman R; Gorelik E
Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
[TBL] [Abstract][Full Text] [Related]
18. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
19. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
